Genomics and genome-editing inquiry
Inquiry by the Science and Technology Committee (Commons), 24 November 2016 to 3 May 2017. Its page on the Parliament website.
Reports and responses
Evidence sessions
- 8 February 2017: Professor Sue Hill, Chief Scientific Officer, NHS England, Professor Mark Caulfield, Chief Scientist, Genomics England, and Dr Julia Wilson, Associate Director, Wellcome Trust Sanger Institute; Professor Sir John Burn, Non-executive Director, NHS England, Professor Dame Kay Davies, Non-executive Director, Genomics England, and Dr Helen Firth, Clinical Lead, Deciphering Developmental Disorders Project, Wellcome Trust Sanger Institute
- 8 March 2017: Dr Edward Hockings, Founder, Ethics and Genetics, Professor Michael Parker, Director, Ethox Centre, University of Oxford, and Non-executive Director and Chair, Ethics Advisory Committee, Genomics England, Peter Counter, Chief Information Officer and Project Manager, Genomics England, and Alison Hall, Head of Humanities, PHG Foundation; Professor Sir Mike Stratton, Director, Wellcome Trust Sanger Institute, and Chief Executive Officer, Wellcome Genome Campus, and Dr Jean Abraham, Academic Honorary Consultant in Medical Oncology, University of Cambridge
- 29 March 2017: Professor Waseem Qasim, Professor of Cell and Gene Therapy, Institute of Child Health, Alastair Kent, Director, Genetic Alliance UK, and Dr Kathy Niakan, Group Leader, Francis Crick Institute; Dr Andy Greenfield, Programme Leader, Medical Research Council's Harwell Institute, Robin Lovell-Badge, Senior Group Leader, Francis Crick Institute, James Lawford Davies, Partner, Hempsons, and Philippa Taylor, Head of Public Policy, Christian Medical Fellowship